Shape 22 Experience

SARS-CoV-2 Antibody Assays​*

Request more info

Our SARS-CoV-2 Total and IgG antibody assays* provide a quantitative and/or qualitative result. Quantitative measurements of SARS-CoV-2 antibodies help clinicians assess the level of an individual‘s immune response. This numerical value will enable detection of the level of antibodies in a patient’s blood sample. Clinicians will have a baseline and be better equipped to assess changes during the course of an individual’s immune response to the SARS-CoV-2 virus.​

The SARS-CoV-2 IgG* and SARS-CoV-2 Total* assays detect antibodies to the receptor-binding domain (RBD) of the S1 spike antigen, the most unique portion of the SARS-CoV-2 virus.1,2

Assay

System

Positive Percent

Agreement

Negative Percent

Agreement

sCOVG

Atellica IM

ADVIA Centaur

95.58%

95.58%

99.90%

99.90%

COV2T

Atellica IM

ADVIA Centaur

98.51%

98.73%

99.82%

99.81%

1
2